For: | Roth G, Teyssier Y, Benhamou M, Abousalihac M, Caruso S, Sengel C, Seror O, Ghelfi J, Seigneurin A, Ganne-Carrie N, Gigante E, Blaise L, Sutter O, Decaens T, Nault JC. Impact of sarcopenia on tumor response and survival outcomes in patients with hepatocellular carcinoma treated by trans-arterial (chemo)-embolization. World J Gastroenterol 2022; 28(36): 5324-5337 [PMID: PMC9521519 DOI: 10.3748/wjg.v28.i36.5324] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v28/i36/5324.htm |
Number | Citing Articles |
1 |
Xuanmei Li, Xue Huang, Lifu Lei, Shiwen Tong. Impact of sarcopenia and sarcopenic obesity on survival in patients with primary liver cancer: a systematic review and meta-analysis. Frontiers in Nutrition 2023; 10 doi: 10.3389/fnut.2023.1233973
|
2 |
Thanatchawan Polvieng, Sermsak Hongjinda, Anuparp Thienhiran, Pipit Burasakarn, Pusit Fuengfoo. Effect of Sarcopenia on the Prognosis of Clinical Outcomes in Patients With Hepatocellular Carcinoma After Hepatic Resection. The American Surgeon™ 2024; 90(6): 1447 doi: 10.1177/00031348241241713
|
3 |
Ken Sato, Yu Miyauchi, Xinran Xu, Risako Kon, Nobutomo Ikarashi, Yoshihiko Chiba, Tomoo Hosoe, Hiroyasu Sakai. Platinum-based anticancer drugs-induced downregulation of myosin heavy chain isoforms in skeletal muscle of mouse. Journal of Pharmacological Sciences 2023; 152(3): 167 doi: 10.1016/j.jphs.2023.04.009
|
4 |
Annalisa Cespiati, Daniel Smith, Rosa Lombardi, Anna Ludovica Fracanzani. The Negative Impact of Sarcopenia on Hepatocellular Carcinoma Treatment Outcomes. Cancers 2024; 16(13): 2315 doi: 10.3390/cancers16132315
|
5 |
Abdul Maajid Khokhar, Ayyaz Khan, Zartash Gull. Impact of Trans-Arterial Chemo-Embolization on Tumor Response in Hepatocellular Carcinoma Patients: A Retrospective Study. Pakistan BioMedical Journal 2023; : 29 doi: 10.54393/pbmj.v6i09.933
|
6 |
Jing Long, Xin Zhang, Wei Mi, Jianjun Shi, Hongwei Ren, Qiang Wang. The predictive value of sarcopenia and myosteatosis in trans-arterial (chemo)-embolization treated HCC patients. Aging 2024; doi: 10.18632/aging.205375
|
7 |
Yen-Chun Chen, Meng-Hsuan Kuo, Ching-Sheng Hsu, I-Ting Kao, Chen-Yi Wu, Chih-Wei Tseng, Shih-Chieh Shao. Impact of Low Muscle Mass on Hepatocellular Carcinoma Patients Undergoing Transcatheter Liver-Directed Therapies: Systematic Review & Meta-Analysis. Cancers 2024; 16(2): 319 doi: 10.3390/cancers16020319
|
8 |
Giorgio Esposto, Raffaele Borriello, Linda Galasso, Fabrizio Termite, Irene Mignini, Lucia Cerrito, Maria Elena Ainora, Antonio Gasbarrini, Maria Assunta Zocco. Ultrasound Evaluation of Sarcopenia in Patients with Hepatocellular Carcinoma: A Faster and Easier Way to Detect Patients at Risk. Diagnostics 2024; 14(4): 371 doi: 10.3390/diagnostics14040371
|
9 |
Francesca Campani, Tancredi Vincenzo Li Cavoli, Umberto Arena, Fabio Marra, Erica Nicola Lynch, Claudia Campani. Quick and easy assessment of sarcopenia in cirrhosis: Can ultrasound be the solution?. World Journal of Gastroenterology 2024; 30(17): 2287-2293 doi: 10.3748/wjg.v30.i17.2287
|
10 |
Ken Sato, Yoshida Satoshi, Yu Miyauchi, Fumiaki Sato, Risako Kon, Nobutomo Ikarashi, Yoshihiko Chiba, Tomoo Hosoe, Hiroyasu Sakai. Downregulation of PGC-1α during cisplatin-induced muscle atrophy in murine skeletal muscle. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2024; 1870(1): 166877 doi: 10.1016/j.bbadis.2023.166877
|
11 |
Attapon Rattanasupar, Tanaporn Prateepchaiboon, Keerati Akarapatima, Apiradee Songjamrat, Songklod Pakdeejit, Arunchai Chang. Impact of pre-sarcopenia on outcomes of transarterial chemoembolization in unresectable hepatocellular carcinoma. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-70266-0
|